In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression.  To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examines data to suggest that, for some individuals with virologic suppression, switching to long-acting ART may address internalized HIV stigma. Finally, Dr Huhn takes a look at the optimal candidates for switching to a long-acting ART regimen and se ..read more

In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including:  Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma) Applying CDC recommendations for universal HBV screening in adults  Strategies to improve HBV transitions of care (eg, improved education, simplify criteria for screening and monitoring, alternative testing sites) Importance of testing close contacts for HBV after in ..read more

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: New data surrounding long-acting ART, including: The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to oral ART Updated data from San Francisco’s Ward 86 Clinic using LA CAB + RPV in people without vir ..read more

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University ..read more

In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Opportunities to improve patient education, including education for expectant mothers with HBV Potential cultural considerations that may result in delayed HBV diagnosis and care  Stigma reduction with universal HBV screening and vaccination Strategies to improve patient education (eg, online resources, advocacy groups, use of layman’s terms and diagrams, repetition) Presenter:  Robert Wong, MD, MS  Clinical Associate Professor&n ..read more

Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including: Polypharmacy and deprescribing The risk of cardiovascular events with various ART regimens Approaches for managing weight gain Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care System Dallas, Texas Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. To downloa ..read more

In this episode, Dr. Bedimo discusses best practices for individualized care in transgender women living with HIV, including: Providing services in a gender-affirmative care model Proactive counseling on drug-drug interactions with gender-affirming hormone therapy Strategies to reduce adverse events Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care System Dallas, Texas Get access to all of our new podcasts by subscribing to the CCO Infectious D ..read more

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes: Current COVID-19 landscape COVID-19 testing and vaccination recommendations Treatment guidelines and antiviral options for nonhospitalized adults with COVID-19 Resources for assessing and managing COVID-19 antiviral-related drug-drug interactions Answers to learners’ most pressing questions  Presenters: Renslow Sherer, MD Director Inte ..read more

In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: Current therapies Studies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDF Kaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis B Early vs Late Postpartum Cessation of TDF Initiated for Prevention of Vertical HBV Transmission Investigational functional cure strategies B-Together: Sequential Bepirovirsen and PegIFN Added to NA Therapy for Chronic HBV Infection MARCH Part B: VIR-3434 ± VIR-2218 ± PegIFN Added ..read more

In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: Racial disparities in the PrEP care continuum Consideration that PrEP persistence may be less about relationship to the drug than the environment Examples of HCP implicit bias regarding PrEP responsibility based on racism and sexual prejudice Impact of HCP implicit bias on PrEP persiste ..read more